B. Manjarrez-Téllez

发表

Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy

R. Ribas-Aparicio, J. Zenteno, A. Gómez-Delgado, 2021, Pharmacogenetics and genomics.

Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients

J. Gaytán-Martínez, J. A. Mata-Marín, J. Sandoval-Ramírez, 2015, AIDS Research and Therapy.

APRI as a predictor of early viral response in chronic hepatitis C patients.

J. L. Fuentes-Allen, J. Gaytán-Martínez, J. A. Mata-Marín, 2009, World journal of gastroenterology.

Boceprevir in Mexico: Experience in a Series of Cases

J. Gaytán-Martínez, J. A. Mata-Marín, Alberto Chaparro-Sánchez, 2014 .

Anal intraepithelial neoplasia among HIV-positive men who have sex with men.

J. Gaytán-Martínez, J. A. Mata-Marín, J. Sandoval-Ramírez, 2015, Sexual Health.

Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico

J. Gaytán-Martínez, L. Ochoa-Carrera, J. A. Mata-Marín, 2015, BMC Research Notes.

Dyslipidemia and Fasting Glucose Impairment among HIV-InfectedPatients 48-Weeks after the First Antiretroviral Regimen

A.Lara, J. Juan, J. Gaytán-Martínez, 2015 .

Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.

J. Gaytán-Martínez, J. A. Mata-Marín, B. Manjarrez-Téllez, 2015, AIDS patient care and STDs.

Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.

Gloria Huerta García, J. Gaytán-Martínez, J. A. Mata-Marín, 2016, Journal of Infection in Developing Countries.

Intensification of treatment with pegylated interferon alfa in patients coinfected with HIV and HBV genotype H or G being treated with a tenofovir/emtricitabine-containing regimen.

J. Gaytán-Martínez, J. A. Mata-Marín, C. I. Arroyo-Anduiza, 2014, Hepato-Gastroenterology.